Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 14/20 | 0.58 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.58 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 2/20 | 0.50 |
| ▸ | RGS12 | O14924 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29350881 | 1.00 | HDAC8 (0.58) | HDAC8HDAC3HDAC1HDAC2HDAC6 | |
| SCHEMBL44905 | 1.00 | HDAC8 (0.58) | HDAC8HDAC3HDAC1HDAC2HDAC6 | |
| SCHEMBL1613174 | 1.00 | HDAC8 (0.58) | HDAC8HDAC3HDAC1HDAC2HDAC6 | |
| SCHEMBL5965416 | 0.89 | HDAC8 (0.52) | HDAC8HDAC3HDAC1HDAC2HDAC6 | |
| SCHEMBL21690291 | 0.86 | CYP2C9 (0.51) | HDAC8HDAC3HDAC1HDAC2HDAC6 | |
| SCHEMBL29398382 | 0.86 | CYP2C9 (0.51) | HDAC8HDAC3HDAC1HDAC2HDAC6 | |
| SCHEMBL29398451 | 0.86 | CYP2C9 (0.51) | HDAC8HDAC3HDAC1HDAC2HDAC6 | |
| SCHEMBL12958085 | 0.86 | HDAC8 (0.58) | HDAC8HDAC3HDAC1HDAC2HDAC6 | |
| SCHEMBL29868418 | 0.86 | HDAC8 (0.58) | HDAC8HDAC3HDAC1HDAC2HDAC6 | |
| SCHEMBL15745971 | 0.85 | HDAC8 (0.57) | HDAC8HDAC3HDAC1HDAC2HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023042201-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-03-23 | — | — | WO | claimed |
| CN-105143245-B | Anti-scaling material | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2021-02-05 | — | — | CN | claimed |
| EP-2951195-B1 | ANTIFOULING MATERIALS | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2020-02-19 | — | — | EP | claimed |
| US-9631100-B2 | Antifouling materials | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2017-04-25 | — | — | US | claimed |
| US-20150368480-A1 | ANTIFOULING MATERIALS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2015-12-24 | — | — | US | claimed |
| EP-2951195-A1 | ANTIFOULING MATERIALS | Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. (IL) | 2015-12-09 | — | — | EP | claimed |
| WO-2014118779-A1 | ANTIFOULING MATERIALS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2014-08-07 | — | — | WO | claimed |
| US-8486370-B2 | Heterocyclic ligands for integrin imaging and therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-07-16 | — | — | US | claimed |
| US-20110195907-A1 | AMINO ACID AND PEPTIDE CONJUGATES OF AMILORIDE AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA OFFICE OF TECHNOLOGY TRANSFER (US) | 2011-08-11 | — | — | US | claimed |
| US-7863415-B2 | Amino acid and peptide conjugates of amiloride and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-01-04 | — | — | US | claimed |
| US-20100310455-A1 | Heterocyclic Ligands for Integrin Imaging and Therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-12-09 | — | — | US | claimed |
| US-7576175-B2 | Amino acid terminated diphenylurea derivatives; display high binding affinity, specificity, and stability; use in treating cancer, inflammatory diseases, and autoimmune diseases | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-08-18 | — | — | US | claimed |
| US-20060160746-A1 | Amino acid and peptide conjugates of amiloride and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-07-20 | — | — | US | claimed |
| WO-2005073247-A1 | AMINO ACID AND PEPTIDE CONJUGATES OF AMILORIDE AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-08-11 | — | — | WO | claimed |
| US-20260116855-A1 | ORALLY ACTIVE MELANOCORTIN RECEPTOR-4 COMPOUNDS | PALATIN TECHNOLOGIES INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12612605-B2 | Carboxyesterase polypeptides for kinetic resolution | CODEXIS, INC. (US) | 2026-04-28 | — | — | US | disclosed |
| US-20260083852-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | UNIV CALIFORNIA (US) | 2026-03-26 | — | — | US | disclosed |
| EP-0859785-A1 | CYCLIC PEPTIDE ANALOGS OF SOMATOSTATIN | BIOMEASURE, INC. (US) | 1998-08-26 | — | — | EP | disclosed |
| US-5708135-A | INHIBIT INSULIN RELEASE, TREATMENT OF DIABETES, MEDICAL IMAGING WITH IODINATED DERIVATIVES | BIOMEASURE INCORPORATED (US) | 1998-01-13 | — | — | US | disclosed |
| WO-1997011962-A1 | CYCLIC PEPTIDE ANALOGS OF SOMATOSTATIN | BIOMEASURE, INCORPORATED (US) | 1997-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100310455-A1 | Heterocyclic Ligands for Integrin Imaging and Therapy | ITGA1, ITGAL, ITGA4 | HDAC8 1295/4885HDAC3 634/4885HDAC1 755/4885 |
| US-20110195907-A1 | AMINO ACID AND PEPTIDE CONJUGATES OF AMILORIDE AND METHODS OF USE THEREOF | VIP, SLC1A1, SLC1A3 | HDAC8 3874/4885HDAC3 3914/4885HDAC1 3239/4885 |
| US-12612605-B2 | Carboxyesterase polypeptides for kinetic resolution | CES1, CPA1, RNGTT | HDAC8 2821/4885HDAC3 4548/4885HDAC1 4800/4885 |
| US-20260083852-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | PDGFA, DCLRE1A, PDGFRA | HDAC8 4499/4885HDAC3 3823/4885HDAC1 4204/4885 |
| US-20060160746-A1 | Amino acid and peptide conjugates of amiloride and methods of use thereof | VIP, SLC1A1, SLC1A3 | HDAC8 3874/4885HDAC3 3914/4885HDAC1 3239/4885 |
| US-20260116855-A1 | ORALLY ACTIVE MELANOCORTIN RECEPTOR-4 COMPOUNDS | MC1R, MC3R, MC5R | HDAC8 532/4885HDAC3 426/4885HDAC1 821/4885 |
| US-20150368480-A1 | ANTIFOULING MATERIALS | PFAS, FLNB, FLNA | HDAC8 4472/4885HDAC3 1422/4885HDAC1 3146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.